Rapid changes in cardiac myofilament function following the acute activation of estrogen receptor-alpha

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Kulpa, Justyna ^a   Chinnappareddy, Nirmala ^a   Pyle, W Glen ^a,b  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN ADENOSINE TRIPHOSPHATASE; TROPONIN I;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIAC MYOFILAMENT; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HEART FUNCTION; HEART MUSCLE CELL; MYOFILAMENT; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HEART VENTRICLES; IMIDAZOLES; MICE; MICE, INBRED C57BL; MUSCLE PROTEINS; MYOFIBRILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOLS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PYRAZOLES; PYRIDINES; TROPONIN I; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

MUS;

EID: 84864427158     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041076     Document Type: Article

References (32)

1. Mendelsohn ME, Karas RH, ((1999)) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:: 1801--1811.
2. Stampfer MJ, Colditz GA, ((1991)) Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20:: 47--63.
3. Donaldson C, Eder S, Baker C, Aronovitz MJ, Weiss AD, et al. ((2009)) Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Circ Res 104: 265-275, 211p following 275.
4. Gardner JD, Brower GL, Voloshenyuk TG, Janicki JS, ((2008)) Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens. Am J Physiol Heart Circ Physiol 294:: H198--204.
5. Pedram A, Razandi M, Lubahn D, Liu J, Vannan M, et al. ((2008)) Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin. Endocrinology 149:: 3361--3369.
6. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, et al. ((2004)) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291:: 1701--1712.
7. Hulley S, Grady D, Bush T, Furberg C, Herrington D, et al. ((1998)) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280:: 605--613.
8. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, et al. ((2003)) Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349:: 523--534.
9. Dubey RK, Imthurn B, Barton M, Jackson EK, ((2005)) Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc Res 66:: 295--306.
10. Grohe C, Kahlert S, Lobbert K, Vetter H, ((1998)) Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. J Endocrinol 156:: R1--7.
11. Lizotte E, Grandy SA, Tremblay A, Allen BG, Fiset C, ((2009)) Expression, distribution and regulation of sex steroid hormone receptors in mouse heart. Cell Physiol Biochem 23:: 75--86.
12. Deschamps AM, Murphy E, ((2009)) Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol 297:: H1806--1813.
13. Ropero AB, Eghbali M, Minosyan TY, Tang G, Toro L, et al. ((2006)) Heart estrogen receptor alpha: distinct membrane and nuclear distribution patterns and regulation by estrogen. J Mol Cell Cardiol 41:: 496--510.
14. Booth EA, Obeid NR, Lucchesi BR, ((2005)) Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 289:: H2039--2047.
15. Novotny JL, Simpson AM, Tomicek NJ, Lancaster TS, Korzick DH, ((2009)) Rapid estrogen receptor-alpha activation improves ischemic tolerance in aged female rats through a novel protein kinase C epsilon-dependent mechanism. Endocrinology 150:: 889--896.
16. Hsu JT, Hsien YC, Kan WH, Chen JG, Choudhry MA, et al. ((2007)) Role of p36 mitogen-activated protein kinase pathway in estrogen-mediated cardioprotection following trauma-hemorrhage. Am J Physiol Heart Circ Physiol 292:: H2982--H2987.
17. Nuedling S, Kahlert S, Loebbert K, Meyer R, Vetter H, et al. ((1999)) Differential effects of 17beta-estradiol on mitogen-activated protein kinase pathways in rat cardiomyocytes. FEBS Lett 454:: 271--276.
18. Wattanapermpool J, ((1998)) Increase in calcium responsiveness of cardiac myofilament activation in ovariectomized rats. Life Sci 63:: 955--964.
19. Wattanapermpool J, Riabroy T, Preawnim S, ((2000)) Estrogen supplement prevents the calcium hypersensitivity of cardiac myofilaments in ovariectomized rats. Life Sci 66:: 533--543.
20. Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, et al. ((2006)) Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem Pharmacol 71:: 1459--1469.
21. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, et al. ((1999)) Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:: 401--406.
22. Pyle WG, Chen Y, Hofmann PA, ((2003)) Cardioprotection through a PKC-dependent decrease in myofilament ATPase. Am J Physiol Heart Circ Physiol 285:: H1220--1228.
23. Pyle WG, Smith TD, Hofmann PA, ((2000)) Cardioprotection with kappa-opioid receptor stimulation is associated with a slowing of cross-bridge cycling. Am J Physiol Heart Circ Physiol 279:: H1941--1948.
24. Yang F, Aiello DL, Pyle WG, ((2008)) Cardiac myofilament regulation by protein phosphatase type 1alpha and CapZ. Biochem Cell Biol 86:: 70--78.
25. Patton C, Thompson S, Epel D, ((2004)) Some precautions in using chelators to buffer metals in biological solutions. Cell Calcium 35:: 427--431.
26. Schaible TF, Malhotra A, Ciambrone G, Scheuer J, ((1984)) The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res 54:: 38--49.
27. Scheuer J, Malhotra A, Schaible TF, Capasso J, ((1987)) Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res 61:: 12--19.
28. Jiang C, Poole-Wilson PA, Sarrel PM, Mochizuki S, Collins P, et al. ((1992)) Effect of 17 beta-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 106:: 739--745.
29. Ullrich ND, Krust A, Collins P, MacLeod KT, ((2008)) Genomic deletion of estrogen receptors ERalpha and ERbeta does not alter estrogen-mediated inhibition of Ca2+ influx and contraction in murine cardiomyocytes. Am J Physiol Heart Circ Physiol 294:: H2421--2427.
30. Filice E, Angelone T, De Francesco EM, Pellegrino D, Maggiolini M, et al. ((2011)) Crucial role of phospholamban phosphorylation and S-nitrosylation in the negative lusitropism induced by 17beta-estradiol in the male rat heart. Cell Physiol Biochem 28:: 41--52.
31. Wang M, Crisostomo P, Wairiuko GM, Meldrum DR, ((2006)) Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol 290:: H2204--2209.
32. Bell JR, Mellor KM, Wollermann AC, Ip WT, Reichelt ME, et al. ((2011)) Aromatase deficiency confers paradoxical postischemic cardioprotection. Endocrinology 152:: 4937--4947.